bylvay
albireo - odevixibat - cholestasis, intrahepatic - bile- ja maksanhoito - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 ja 5.
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
venlafaxine bluefish 75 mg depotkapseli, kova
bluefish pharmaceuticals ab bluefish pharmaceuticals ab - venlafaxini hydrochloridum - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxine bluefish 150 mg depotkapseli, kova
bluefish pharmaceuticals ab bluefish pharmaceuticals ab - venlafaxini hydrochloridum - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxin hexal 75 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin hexal 150 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxin hexal 37.5 mg depotkapseli, kova
hexal a/s - venlafaxini hydrochloridum - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin orion 37.5 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin orion 75 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin orion 150 mg depotkapseli, kova
orion corporation - venlafaxine hydrochloride - depotkapseli, kova - 150 mg - venlafaksiini